Company Snapshot: HGSI  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference

   Human Genome Sciences, Inc. logo. (PRNewsFoto/Human Genome Sciences, Inc.)

ROCKVILLE, MD UNITED STATES
    ROCKVILLE, Md., Jan. 4 /PRNewswire-FirstCall/ -- Human Genome Sciences,
Inc. (Nasdaq: HGSI) announced today that its presentation at the 26th
Annual JPMorgan Healthcare Conference will be webcast and may be accessed
at http://www.hgsi.com

    (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

    A member of Human Genome Sciences' senior management team will present
an overview of the company on Wednesday, January 9, 2008 at 7:30 am Pacific
Time, or 10:30 am Eastern Time.

    Investors interested in listening to the live webcast should log on
before the start time in order to download any software required. The
archive of the webcast will be available for several days after the live
event.

    The mission of HGS is to apply great science and great medicine to
bring innovative drugs to patients with unmet medical needs.

    HGS and Human Genome Sciences are registered trademarks of Human Genome
Sciences, Inc. For additional information on Human Genome Sciences, Inc.,
visit the company's web site at http://www.hgsi.com.



SOURCE Human Genome Sciences, Inc.




Back to Topback to top

Related links:
  • http://www.hgsi.com
    Photo Notes:
    NewsCom: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO
    AP Archive: http://photoarchive.ap.org
    PRN Photo Desk, photodesk@prnewswire.com
  • http://www.prnewswire.com/comp/121115.html/
    CONTACT:
    Jerry Parrott, Vice President, Corporate
    Communications, +1-301-315-2777, or Kate de Santis, Director,
    Investor Relations, +1-301-251-6003, both of Human Genome
    Sciences, Inc.